Skip to the page

Data / Medical devices / Japan / Seikagaku Corporation, Takahagi Plant

Seikagaku Corporation, Takahagi Plant: FDA-registered device maker in TAKAHAGI-SHI Ibaraki, Japan, 2 PMA approvals

Seikagaku Corporation, Takahagi Plant is registered with the FDA (registration 9612392) in TAKAHAGI-SHI Ibaraki, Japan. It lists 1 device type. The FDA files 2 PMA approvals under its listings, the newest dated March 22, 2011. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
9612392
FEI number
1000255210
Address
258-5, Aza-Matsukubo Oaza-Akahama, TAKAHAGI-SHI Ibaraki, Japan, 318-0001
Owner or operator
SEIKAGAKU CORPORATION (9043759)
Roles
Manufacturer
First device listed
December 17, 2007
Registered through
2026
Brand names listed
Gel-One, SUPARTZ FX, VISCO-3

Devices it lists

DeviceProduct codeClassRoleSource
Acid, Hyaluronic, IntraarticularMOZ3Manufactureraccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
March 22, 2011P080020GEL-ONEMOZ54September 4, 2026accessdata.fda.gov
January 24, 2001P980044SUPARTZ FXMOZ62September 4, 2026accessdata.fda.gov

Compare with other makers

Updated September 4, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.